Skip to the story
All StoriesPoliticsConflict & SecurityBusiness & EconomyScience & TechHealthClimateMedia
All stories
Health65 outlets ran this4 min read

Congo receives 70,000 doses of Ervebo vaccine amid Ebola outbreak

WHO allocates unlicensed vaccine for Bundibugyo strain as cases surpass 5,000 and deaths reach 2,476

AI-assisted coverage comparison, editor-supervised · How this was made

Published
Camera IconExperts hope the Ervebo Ebola vaccine will have an impact on the Bundibugyo strain of the virus. (EPA PHOTO) Credit: AAP

What this story says

  • Congo will receive 70,000 doses of the Ervebo vaccine, which is licensed for the Zaire strain of Ebola but not the Bundibugyo strain causing the current outbreak.
  • The World Health Organization stated early data suggest Ervebo might provide some protection against Bundibugyo, though this is unconfirmed.
  • Of the 70,000 doses, 50,000 are allocated for frontline workers and 20,000 for a phase 3 trial to test efficacy against Bundibugyo.
  • The outbreak in eastern Congo has resulted in 2,476 deaths since May 2026, with cases spreading faster than in previous outbreaks.

Who covered it

Left 29%(12)Centre 47%(19)Right 24%(10)

Percentages are shares of the 41 outlets carrying a published leaning rating. 24 of the 65 outlets we know ran this story carry no rating and are not counted in them. Coverage measured .

Trust

82/100

Craft

75/100

Hype

15/100

65 sources · methodology

The World Health Organization announced on 20 August 2026 that Congo would receive 70,000 doses of the Ervebo Ebola vaccine. The vaccine is licensed for the Zaire strain of Ebola but not for the Bundibugyo strain, which is responsible for the current outbreak in eastern Congo. The WHO stated that early laboratory and animal data suggest Ervebo might offer some protection against Bundibugyo, though this remains unproven.

The 70,000 doses are divided into two allocations: 50,000 for frontline and healthcare workers, and 20,000 for a phase 3 clinical trial to assess the vaccine’s effectiveness against the Bundibugyo strain. The outbreak, declared in May 2026, has seen 2,476 deaths among confirmed cases, according to the WHO. The spread has been described as faster than any previous Ebola outbreak, including the 2014-16 West Africa epidemic.

What the coverage left out

None of the digests from left-rated outlets mentioned that most new cases are occurring outside monitored groups, a detail included in the full report by PerthNow. The right-rated digests did not carry this detail either. The full report in PerthNow also noted the outbreak is spreading about three times faster than the 2014-16 West Africa epidemic, a comparison absent from all digests.

Tags:#EbolaOutbreak#CongoHealthCrisis#ErveboVaccine#WHOEmergencyResponse#BundibugyoStrain

Still developing. We have re-checked which outlets are covering this 1 time, most recently on 20 Aug 2026, 13:15, and will add the sides that appear.

How each side covered it

Our own reading of the reporting listed below, written from the outlets’ articles rather than quoted from them. The reasoning is set out on our methodology page.

Left

12 rated outlets

  • The six left-rated digests below led on the arrival of the 70,000 Ervebo doses as a significant step in containing the outbreak. All included the WHO’s statement that the vaccine has been effective in past outbreaks. Five of the six digests noted the vaccine is not licensed for the Bundibugyo strain, and three mentioned the 20,000 doses reserved for a phase 3 trial. None of the left-rated digests omitted the death toll or the speed of the outbreak.

Centre

19 rated outlets

  • The eight centre-rated digests below carried the WHO’s allocation of 70,000 doses, with seven specifying the split between frontline workers and the phase 3 trial. All eight noted the vaccine is licensed for the Zaire strain but not Bundibugyo, and seven included the WHO’s statement that early data suggest possible protection. The full report in PerthNow described the outbreak as the fastest in history and quoted officials on the lack of approved vaccines for Bundibugyo.

Right

10 rated outlets

  • The seven right-rated digests below reported the 70,000-dose allocation, with five noting the vaccine’s unlicensed status for the Bundibugyo strain. Four mentioned the phase 3 trial, and three included the death toll. The digests in Free Malaysia Today and Emirates24|7 described the outbreak as fast-spreading. None of the right-rated digests omitted the WHO’s statement on early data suggesting possible protection.

Read it at the source

65 outlets, grouped by the leaning a published rating gives them. Every headline links to the original; an underlined outlet name opens our profile of that publisher.

Left

12
Show 4 more

Centre

19
Show 11 more

Right

10
Show 2 more

Not rated

24
Show 16 more

Questions about this coverage

How did the left and right cover Congo receives 70,000 doses of Ervebo vaccine amid Ebola outbreak?
Of the 41 outlets on this story carrying a published leaning rating, 29% are rated left, 47% are rated centre, 24% are rated right. Those percentages are shares of the rated outlets, not of every outlet that ran it, which was 65. The sections above set out what each side emphasised, in its own terms.
Is Congo receives 70,000 doses of Ervebo vaccine amid Ebola outbreak left or right?
Neither side dominates it. Of the 41 rated outlets on this story, 29% are rated left, 47% are rated centre, 24% are rated right, and no side holds the 70% this site would want before calling a field one-sided. A story is not left or right in any case; the outlets that carried it are what carry ratings.
Is the coverage of Congo receives 70,000 doses of Ervebo vaccine amid Ebola outbreak biased?
Congo receives 70,000 doses of Ervebo vaccine amid Ebola outbreak is one event reported by 65 outlets, and this page does not rate the story as biased or unbiased. What it publishes is the spread: which outlets ran it, where named rating organisations place each of them on the spectrum, and what each side chose to lead with. A leaning rating describes an outlet's record over time, not this article, and the two should not be run together.
Which outlets covered Congo receives 70,000 doses of Ervebo vaccine amid Ebola outbreak?
65 that we know of, every one of them listed further up this page with a link to its own report and to what we hold on the publisher. Nothing here is a summary of somebody else's summary: the outlets are named so the original reporting can be read.
How many doses of the Ervebo vaccine is Congo receiving?
Congo is receiving 70,000 doses of the Ervebo vaccine, as announced by the World Health Organization. Of these, 50,000 are for frontline workers and 20,000 are reserved for a phase 3 trial to test the vaccine’s effectiveness against the Bundibugyo strain.
Is the Ervebo vaccine effective against the current Ebola strain in Congo?
The Ervebo vaccine is licensed for the Zaire strain of Ebola but not the Bundibugyo strain causing the current outbreak. The WHO stated early data suggest it might provide some protection against Bundibugyo, though this is unconfirmed and the subject of a phase 3 trial.
How many people have died in the current Ebola outbreak in Congo?
The outbreak in eastern Congo has resulted in 2,476 deaths since it was declared in May 2026. The World Health Organization reported the outbreak is spreading faster than any previous Ebola epidemic, including the 2014-16 West Africa outbreak.

How did this read?

About the coverage, not about the story. We do not ask whether you agree with what happened — we have no honest use for that answer.

More in Health

All Health →
Surrogate McKenna West sued for $100,000 after refusing abortion for baby with heart condition6 min readSurrogate McKenna West sued for $100,000 after refusing abortion for baby with heart conditionRead storyMinnesota charges former 'Outstanding Refugee' Salman Ahmed Elmi in $1.5m Medicaid fraud case5 min readMinnesota charges former 'Outstanding Refugee' Salman Ahmed Elmi in $1.5m Medicaid fraud caseRead storyModerna and Merck report melanoma vaccine trial success in phase three4 min readModerna and Merck report melanoma vaccine trial success in phase threeRead story

Elsewhere on the site

Tom Fletcher, United Nations Under-Secretary-General for Humanitarian Affairs and Emergency Relief Coordinator, speaks during an interview in Kyiv, Ukraine, Wednesday, Aug. 19, 2026. (AP Photo/Dan Bashakov)Conflict & Security•4 min readRussian drone attacks in Kherson endanger civilians and aid workers, UN saysWide view of Monrovia, Liberia, from the top of the Ducor Hotel, Sunday, June 15, 2025. (AP Photo/Annie Risemberg, File)Politics•4 min readUS deports 20 migrants to Liberia under 1,200-person resettlement dealUne rue près du port de Lomé (Togo), en février 2026. (OLYMPIA DE MAISMONT / AFP)Media•5 min readTwo French journalists detained in Togo on visa charges after filming near restricted zoneKenya triples renewable energy target to 5,500 MW, including nuclear powerBusiness & Economy•5 min readKenya triples renewable energy target to 5,500 MW, including nuclear power
Congo receives 70,000 Ervebo vaccine doses for Ebola outbreak | MediaBias News